Spatiotemporal Proteomic Profiling of Huntington’s Disease Inclusions Reveals Widespread Loss of Protein Function

Aggregation of polyglutamine-expanded huntingtin exon 1 (HttEx1) in Huntington’s disease (HD) proceeds from soluble oligomers to late-stage inclusions. The nature of the aggregates and how they lead to neuronal dysfunction is not well understood. We employed mass spectrometry (MS)-based quantitative...

Full description

Bibliographic Details
Main Authors: Fabian Hosp, Sara Gutiérrez-Ángel, Martin H. Schaefer, Jürgen Cox, Felix Meissner, Mark S. Hipp, F.-Ulrich Hartl, Rüdiger Klein, Irina Dudanova, Matthias Mann
Format: Article
Language:English
Published: Elsevier 2017-11-01
Series:Cell Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124717315772
id doaj-6eb49d931f08402aa04d09c42c8ca559
record_format Article
spelling doaj-6eb49d931f08402aa04d09c42c8ca5592020-11-25T00:12:11ZengElsevierCell Reports2211-12472017-11-012182291230310.1016/j.celrep.2017.10.097Spatiotemporal Proteomic Profiling of Huntington’s Disease Inclusions Reveals Widespread Loss of Protein FunctionFabian Hosp0Sara Gutiérrez-Ángel1Martin H. Schaefer2Jürgen Cox3Felix Meissner4Mark S. Hipp5F.-Ulrich Hartl6Rüdiger Klein7Irina Dudanova8Matthias Mann9Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Am Klopferspitz 18, 82152 Martinsried, GermanyDepartment Molecules-Signaling-Development, Max Planck Institute of Neurobiology, Am Klopferspitz 18, 82152 Martinsried, GermanyEMBL/CRG Systems Biology Research Unit, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Dr. Aiguader 88, 08003 Barcelona, SpainComputational Systems Biochemistry Laboratory, Max Planck Institute of Biochemistry, Am Klopferspitz 18, 82152 Martinsried, GermanyExperimental Systems Immunology Laboratory, Max Planck Institute of Biochemistry, Am Klopferspitz 18, 82152 Martinsried, GermanyDepartment of Cellular Biochemistry, Max Planck Institute of Biochemistry, Am Klopferspitz 18, 82152 Martinsried, GermanyDepartment of Cellular Biochemistry, Max Planck Institute of Biochemistry, Am Klopferspitz 18, 82152 Martinsried, GermanyDepartment Molecules-Signaling-Development, Max Planck Institute of Neurobiology, Am Klopferspitz 18, 82152 Martinsried, GermanyDepartment Molecules-Signaling-Development, Max Planck Institute of Neurobiology, Am Klopferspitz 18, 82152 Martinsried, GermanyDepartment of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Am Klopferspitz 18, 82152 Martinsried, GermanyAggregation of polyglutamine-expanded huntingtin exon 1 (HttEx1) in Huntington’s disease (HD) proceeds from soluble oligomers to late-stage inclusions. The nature of the aggregates and how they lead to neuronal dysfunction is not well understood. We employed mass spectrometry (MS)-based quantitative proteomics to dissect spatiotemporal mechanisms of neurodegeneration using the R6/2 mouse model of HD. Extensive remodeling of the soluble brain proteome correlated with insoluble aggregate formation during disease progression. In-depth and quantitative characterization of the aggregates uncovered an unprecedented complexity of several hundred proteins. Sequestration to aggregates depended on protein expression levels and sequence features such as low-complexity regions or coiled-coil domains. In a cell-based HD model, overexpression of a subset of the sequestered proteins in most cases rescued viability and reduced aggregate size. Our spatiotemporally resolved proteome resource of HD progression indicates that widespread loss of cellular protein function contributes to aggregate-mediated toxicity.http://www.sciencedirect.com/science/article/pii/S2211124717315772Huntington’s diseaseinclusion bodiescerebrospinal fluidneurodegenerationquantitative proteomics
collection DOAJ
language English
format Article
sources DOAJ
author Fabian Hosp
Sara Gutiérrez-Ángel
Martin H. Schaefer
Jürgen Cox
Felix Meissner
Mark S. Hipp
F.-Ulrich Hartl
Rüdiger Klein
Irina Dudanova
Matthias Mann
spellingShingle Fabian Hosp
Sara Gutiérrez-Ángel
Martin H. Schaefer
Jürgen Cox
Felix Meissner
Mark S. Hipp
F.-Ulrich Hartl
Rüdiger Klein
Irina Dudanova
Matthias Mann
Spatiotemporal Proteomic Profiling of Huntington’s Disease Inclusions Reveals Widespread Loss of Protein Function
Cell Reports
Huntington’s disease
inclusion bodies
cerebrospinal fluid
neurodegeneration
quantitative proteomics
author_facet Fabian Hosp
Sara Gutiérrez-Ángel
Martin H. Schaefer
Jürgen Cox
Felix Meissner
Mark S. Hipp
F.-Ulrich Hartl
Rüdiger Klein
Irina Dudanova
Matthias Mann
author_sort Fabian Hosp
title Spatiotemporal Proteomic Profiling of Huntington’s Disease Inclusions Reveals Widespread Loss of Protein Function
title_short Spatiotemporal Proteomic Profiling of Huntington’s Disease Inclusions Reveals Widespread Loss of Protein Function
title_full Spatiotemporal Proteomic Profiling of Huntington’s Disease Inclusions Reveals Widespread Loss of Protein Function
title_fullStr Spatiotemporal Proteomic Profiling of Huntington’s Disease Inclusions Reveals Widespread Loss of Protein Function
title_full_unstemmed Spatiotemporal Proteomic Profiling of Huntington’s Disease Inclusions Reveals Widespread Loss of Protein Function
title_sort spatiotemporal proteomic profiling of huntington’s disease inclusions reveals widespread loss of protein function
publisher Elsevier
series Cell Reports
issn 2211-1247
publishDate 2017-11-01
description Aggregation of polyglutamine-expanded huntingtin exon 1 (HttEx1) in Huntington’s disease (HD) proceeds from soluble oligomers to late-stage inclusions. The nature of the aggregates and how they lead to neuronal dysfunction is not well understood. We employed mass spectrometry (MS)-based quantitative proteomics to dissect spatiotemporal mechanisms of neurodegeneration using the R6/2 mouse model of HD. Extensive remodeling of the soluble brain proteome correlated with insoluble aggregate formation during disease progression. In-depth and quantitative characterization of the aggregates uncovered an unprecedented complexity of several hundred proteins. Sequestration to aggregates depended on protein expression levels and sequence features such as low-complexity regions or coiled-coil domains. In a cell-based HD model, overexpression of a subset of the sequestered proteins in most cases rescued viability and reduced aggregate size. Our spatiotemporally resolved proteome resource of HD progression indicates that widespread loss of cellular protein function contributes to aggregate-mediated toxicity.
topic Huntington’s disease
inclusion bodies
cerebrospinal fluid
neurodegeneration
quantitative proteomics
url http://www.sciencedirect.com/science/article/pii/S2211124717315772
work_keys_str_mv AT fabianhosp spatiotemporalproteomicprofilingofhuntingtonsdiseaseinclusionsrevealswidespreadlossofproteinfunction
AT saragutierrezangel spatiotemporalproteomicprofilingofhuntingtonsdiseaseinclusionsrevealswidespreadlossofproteinfunction
AT martinhschaefer spatiotemporalproteomicprofilingofhuntingtonsdiseaseinclusionsrevealswidespreadlossofproteinfunction
AT jurgencox spatiotemporalproteomicprofilingofhuntingtonsdiseaseinclusionsrevealswidespreadlossofproteinfunction
AT felixmeissner spatiotemporalproteomicprofilingofhuntingtonsdiseaseinclusionsrevealswidespreadlossofproteinfunction
AT markshipp spatiotemporalproteomicprofilingofhuntingtonsdiseaseinclusionsrevealswidespreadlossofproteinfunction
AT fulrichhartl spatiotemporalproteomicprofilingofhuntingtonsdiseaseinclusionsrevealswidespreadlossofproteinfunction
AT rudigerklein spatiotemporalproteomicprofilingofhuntingtonsdiseaseinclusionsrevealswidespreadlossofproteinfunction
AT irinadudanova spatiotemporalproteomicprofilingofhuntingtonsdiseaseinclusionsrevealswidespreadlossofproteinfunction
AT matthiasmann spatiotemporalproteomicprofilingofhuntingtonsdiseaseinclusionsrevealswidespreadlossofproteinfunction
_version_ 1725400658742345728